| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 APPBP2 ABCA2 MCM8 ABCF2 AK9 FANCM DNAH1 HSPA13 STARD9 ENTPD1 ABCD3 SHOC1 ATP11A DDX60L ATP6V0D2 DNAH8 ABCC10 | 2.90e-06 | 614 | 163 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ABCA2 MCM8 ABCF2 AK9 FANCM HSPA13 ENTPD1 ABCD3 SHOC1 ATP11A DDX60L DNAH8 ABCC10 | 1.62e-05 | 441 | 163 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 ABCA2 MCM8 ABCF2 TUBB2B AK9 FANCM TUBB2A HSPA13 TUBB4B ENTPD1 ABCD3 SHOC1 ATP11A DDX60L GNAZ DNAH8 ABCC10 | 6.55e-05 | 775 | 163 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 6.62e-05 | 2 | 163 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 6.62e-05 | 2 | 163 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 ABCA2 MCM8 ABCF2 TUBB2B AK9 FANCM TUBB2A HSPA13 TUBB4B ENTPD1 ABCD3 SHOC1 ATP11A DDX60L GNAZ DNAH8 ABCC10 | 1.77e-04 | 839 | 163 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 ABCA2 MCM8 ABCF2 TUBB2B AK9 FANCM TUBB2A HSPA13 TUBB4B ENTPD1 ABCD3 SHOC1 ATP11A DDX60L GNAZ DNAH8 ABCC10 | 1.79e-04 | 840 | 163 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 ABCA2 MCM8 ABCF2 TUBB2B AK9 FANCM TUBB2A HSPA13 TUBB4B ENTPD1 ABCD3 SHOC1 ATP11A DDX60L GNAZ DNAH8 ABCC10 | 1.79e-04 | 840 | 163 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 1.84e-04 | 35 | 163 | 4 | GO:0008376 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.69e-04 | 70 | 163 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.34e-04 | 17 | 163 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.34e-04 | 17 | 163 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.98e-04 | 18 | 163 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.19e-04 | 118 | 163 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 9.38e-04 | 189 | 163 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 9.72e-04 | 6 | 163 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.35e-03 | 7 | 163 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.51e-03 | 28 | 163 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.57e-03 | 103 | 163 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.62e-03 | 153 | 163 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.77e-03 | 211 | 163 | 7 | GO:0016758 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 1.75e-05 | 7 | 166 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 2.13e-05 | 42 | 166 | 5 | GO:0099560 | |
| Domain | TPR_10 | 1.38e-05 | 6 | 167 | 3 | PF13374 | |
| Domain | - | APPBP2 TTC16 TRAPPC8 KLC4 CFAP54 P3H1 TTC32 STIP1 GPSM1 KLC1 | 1.76e-05 | 207 | 167 | 10 | 1.25.40.10 |
| Domain | AAA | 4.64e-05 | 144 | 167 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 4.64e-05 | 144 | 167 | 8 | IPR003593 | |
| Domain | TPR-like_helical_dom | APPBP2 TTC16 TRAPPC8 KLC4 CFAP54 P3H1 TTC32 STIP1 GPSM1 KLC1 | 4.82e-05 | 233 | 167 | 10 | IPR011990 |
| Domain | TPR-contain_dom | 6.19e-05 | 150 | 167 | 8 | IPR013026 | |
| Domain | AP3_beta | 7.95e-05 | 2 | 167 | 2 | IPR026740 | |
| Domain | DUF3657 | 7.95e-05 | 2 | 167 | 2 | IPR022122 | |
| Domain | DUF676 | 7.95e-05 | 2 | 167 | 2 | PF05057 | |
| Domain | AP3B_C | 7.95e-05 | 2 | 167 | 2 | IPR029390 | |
| Domain | DUF3657 | 7.95e-05 | 2 | 167 | 2 | PF12394 | |
| Domain | AP3B1_C | 7.95e-05 | 2 | 167 | 2 | PF14796 | |
| Domain | DUF676_lipase-like | 7.95e-05 | 2 | 167 | 2 | IPR007751 | |
| Domain | AP3B1_C | 7.95e-05 | 2 | 167 | 2 | SM01355 | |
| Domain | Beta-tubulin_BS | 8.05e-05 | 10 | 167 | 3 | IPR013838 | |
| Domain | Beta_tubulin | 8.05e-05 | 10 | 167 | 3 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 1.10e-04 | 11 | 167 | 3 | PS00228 | |
| Domain | TPR_REGION | 1.21e-04 | 165 | 167 | 8 | PS50293 | |
| Domain | TPR | 1.21e-04 | 165 | 167 | 8 | PS50005 | |
| Domain | TPR_1 | 1.56e-04 | 90 | 167 | 6 | IPR001440 | |
| Domain | TPR_1 | 1.56e-04 | 90 | 167 | 6 | PF00515 | |
| Domain | TPR | 1.61e-04 | 129 | 167 | 7 | SM00028 | |
| Domain | TPR_repeat | 1.95e-04 | 133 | 167 | 7 | IPR019734 | |
| Domain | KINESIN_LIGHT | 2.37e-04 | 3 | 167 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 2.37e-04 | 3 | 167 | 2 | IPR015792 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.38e-04 | 14 | 167 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.38e-04 | 14 | 167 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.38e-04 | 14 | 167 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.38e-04 | 14 | 167 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.38e-04 | 14 | 167 | 3 | IPR011704 | |
| Domain | MT | 2.38e-04 | 14 | 167 | 3 | PF12777 | |
| Domain | AAA_8 | 2.38e-04 | 14 | 167 | 3 | PF12780 | |
| Domain | AAA_5 | 2.38e-04 | 14 | 167 | 3 | PF07728 | |
| Domain | PTPc | 2.91e-04 | 36 | 167 | 4 | SM00194 | |
| Domain | DHC_fam | 2.95e-04 | 15 | 167 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.95e-04 | 15 | 167 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.95e-04 | 15 | 167 | 3 | IPR004273 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.97e-04 | 39 | 167 | 4 | PS50055 | |
| Domain | Kinesin_light | 4.71e-04 | 4 | 167 | 2 | IPR002151 | |
| Domain | PTPase_domain | 4.82e-04 | 41 | 167 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 4.82e-04 | 41 | 167 | 4 | PF00102 | |
| Domain | ABC_transporter_CS | 5.30e-04 | 42 | 167 | 4 | IPR017871 | |
| Domain | - | 7.16e-04 | 20 | 167 | 3 | 3.30.1330.20 | |
| Domain | AP_beta | 7.81e-04 | 5 | 167 | 2 | IPR026739 | |
| Domain | PKD_2 | 7.81e-04 | 5 | 167 | 2 | IPR003915 | |
| Domain | - | 8.30e-04 | 21 | 167 | 3 | 1.10.287.600 | |
| Domain | ABC_tran | 8.83e-04 | 48 | 167 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.83e-04 | 48 | 167 | 4 | PS50893 | |
| Domain | Tubulin_C | 9.54e-04 | 22 | 167 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 9.54e-04 | 22 | 167 | 3 | IPR018316 | |
| Domain | - | 9.54e-04 | 22 | 167 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 9.54e-04 | 22 | 167 | 3 | SM00865 | |
| Domain | ABC_TRANSPORTER_1 | 9.55e-04 | 49 | 167 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.03e-03 | 50 | 167 | 4 | IPR003439 | |
| Domain | TYR_PHOSPHATASE_1 | 1.05e-03 | 86 | 167 | 5 | PS00383 | |
| Domain | Tub_FtsZ_C | 1.09e-03 | 23 | 167 | 3 | IPR008280 | |
| Domain | Tubulin_C | 1.09e-03 | 23 | 167 | 3 | IPR023123 | |
| Domain | TUBULIN | 1.09e-03 | 23 | 167 | 3 | PS00227 | |
| Domain | Tubulin | 1.09e-03 | 23 | 167 | 3 | IPR000217 | |
| Domain | Tubulin | 1.09e-03 | 23 | 167 | 3 | SM00864 | |
| Domain | Tubulin_CS | 1.09e-03 | 23 | 167 | 3 | IPR017975 | |
| Domain | TYR_PHOSPHATASE_dom | 1.10e-03 | 87 | 167 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.10e-03 | 87 | 167 | 5 | PS50056 | |
| Domain | Rab5-bind | 1.16e-03 | 6 | 167 | 2 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 1.16e-03 | 6 | 167 | 2 | IPR015390 | |
| Domain | Tubulin_FtsZ_GTPase | 1.24e-03 | 24 | 167 | 3 | IPR003008 | |
| Domain | Tubulin | 1.24e-03 | 24 | 167 | 3 | PF00091 | |
| Domain | - | 1.41e-03 | 92 | 167 | 5 | 3.90.190.10 | |
| Domain | PTPc_motif | 1.91e-03 | 59 | 167 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.91e-03 | 59 | 167 | 4 | IPR003595 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.96e-03 | 99 | 167 | 5 | IPR029021 | |
| Domain | Chond_GalNAc | 2.15e-03 | 8 | 167 | 2 | IPR008428 | |
| Domain | CHGN | 2.15e-03 | 8 | 167 | 2 | PF05679 | |
| Domain | BTK | 2.75e-03 | 9 | 167 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 2.75e-03 | 9 | 167 | 2 | IPR001562 | |
| Domain | BTK | 2.75e-03 | 9 | 167 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.75e-03 | 9 | 167 | 2 | PS51113 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.60e-06 | 24 | 121 | 5 | M47671 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.66e-06 | 43 | 121 | 6 | M47669 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.81e-06 | 68 | 121 | 7 | MM14921 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.99e-06 | 25 | 121 | 5 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.99e-06 | 25 | 121 | 5 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.19e-06 | 45 | 121 | 6 | M47670 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.44e-06 | 26 | 121 | 5 | M47672 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.86e-06 | 76 | 121 | 7 | M27215 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.13e-05 | 35 | 121 | 5 | M47774 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.04e-04 | 29 | 121 | 4 | M27948 | |
| Pathway | REACTOME_KINESINS | 1.26e-04 | 57 | 121 | 5 | MM15714 | |
| Pathway | REACTOME_KINESINS | 1.74e-04 | 61 | 121 | 5 | M977 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.21e-04 | 151 | 121 | 7 | M550 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.84e-04 | 17 | 121 | 3 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.84e-04 | 17 | 121 | 3 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.58e-04 | 18 | 121 | 3 | M47753 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 4.86e-04 | 116 | 121 | 6 | MM15715 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.87e-04 | 76 | 121 | 5 | M48037 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.41e-04 | 19 | 121 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.41e-04 | 19 | 121 | 3 | M47813 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 5.41e-04 | 19 | 121 | 3 | M22005 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBB2B FANCM TUBB2A TUBB4B FCGR1A FCGR1BP NUP133 NUP93 HERC5 | 5.73e-04 | 273 | 121 | 9 | M983 |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 6.32e-04 | 20 | 121 | 3 | M47890 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.32e-04 | 20 | 121 | 3 | M27290 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 6.32e-04 | 20 | 121 | 3 | M47911 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.32e-04 | 20 | 121 | 3 | MM14991 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 7.33e-04 | 21 | 121 | 3 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.33e-04 | 21 | 121 | 3 | M47767 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 7.84e-04 | 127 | 121 | 6 | M27181 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 8.43e-04 | 22 | 121 | 3 | M47903 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.51e-04 | 129 | 121 | 6 | MM14894 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 9.64e-04 | 23 | 121 | 3 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 9.64e-04 | 23 | 121 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 9.64e-04 | 23 | 121 | 3 | M47900 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.02e-03 | 52 | 121 | 4 | MM14949 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.09e-03 | 24 | 121 | 3 | MM15658 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.09e-03 | 24 | 121 | 3 | M47700 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.28e-03 | 94 | 121 | 5 | M2843 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.39e-03 | 26 | 121 | 3 | M9648 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.44e-03 | 57 | 121 | 4 | M27251 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.54e-03 | 98 | 121 | 5 | MM15352 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.55e-03 | 27 | 121 | 3 | MM15549 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.55e-03 | 27 | 121 | 3 | M29807 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.55e-03 | 27 | 121 | 3 | M47755 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.55e-03 | 27 | 121 | 3 | MM15674 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.69e-03 | 100 | 121 | 5 | M27650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.73e-03 | 28 | 121 | 3 | M47898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.92e-03 | 29 | 121 | 3 | MM15219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS | 1.98e-03 | 8 | 121 | 2 | M47920 | |
| Pubmed | UBR2 DUSP9 NIBAN2 FCHO2 PPEF2 AP3B1 TUBB2A PTPN4 PPP3CC PTPRD PTPRE PTPRF CCNB2 P3H1 ABCD3 NUP133 STIP1 POC5 NUP93 UTP3 | 2.60e-07 | 1049 | 171 | 20 | 27880917 | |
| Pubmed | 7.38e-07 | 15 | 171 | 4 | 28532839 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 12376545 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 9256245 | ||
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 6.42e-06 | 8 | 171 | 3 | 23246003 | |
| Pubmed | ABCA2 TTC16 AHCTF1 SIDT1 TUBB2B TUBB2A DOCK5 TUBB4B NLRP14 STARD9 AP3B2 ALPK2 | 9.86e-06 | 513 | 171 | 12 | 25798074 | |
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 1.37e-05 | 10 | 171 | 3 | 23986237 | |
| Pubmed | 1.87e-05 | 11 | 171 | 3 | 7832766 | ||
| Pubmed | 1.93e-05 | 166 | 171 | 7 | 34687317 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 2.40e-05 | 2 | 171 | 2 | 37733444 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 30621030 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 9257847 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 25231998 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 30190171 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 2.40e-05 | 2 | 171 | 2 | 2136886 | |
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 2.40e-05 | 2 | 171 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 2.40e-05 | 2 | 171 | 2 | 35833115 | |
| Pubmed | SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy. | 2.40e-05 | 2 | 171 | 2 | 31235251 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 2.40e-05 | 2 | 171 | 2 | 15528358 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 2.40e-05 | 2 | 171 | 2 | 14991835 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1402657 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7665159 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 2.40e-05 | 2 | 171 | 2 | 10752630 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 31211699 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16849450 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 38524127 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8077658 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 2.40e-05 | 2 | 171 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 2.40e-05 | 2 | 171 | 2 | 16305642 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 27476612 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21124939 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 2.40e-05 | 2 | 171 | 2 | 24430180 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23166318 | ||
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 2.40e-05 | 2 | 171 | 2 | 38885133 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 2.40e-05 | 2 | 171 | 2 | 1430234 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15835266 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8663283 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1830050 | ||
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 2.40e-05 | 2 | 171 | 2 | 21325219 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8611682 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16409296 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 27610455 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 2.40e-05 | 2 | 171 | 2 | 17124586 | |
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 2.40e-05 | 2 | 171 | 2 | 8480181 | |
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 2.40e-05 | 2 | 171 | 2 | 29576375 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18245810 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 2.40e-05 | 2 | 171 | 2 | 31554601 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 37279284 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 2.40e-05 | 2 | 171 | 2 | 18049118 | |
| Pubmed | 2.49e-05 | 12 | 171 | 3 | 16018997 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | VMP1 PLXNA3 USP34 UBR2 ABCA2 ANPEP CHSY1 HMGCR EMC8 TFPI HSPA13 OLFML2A CSGALNACT2 PTPRF PRCP P3H1 LRP1 IPO13 | 2.86e-05 | 1201 | 171 | 18 | 35696571 |
| Pubmed | 3.91e-05 | 126 | 171 | 6 | 17897319 | ||
| Pubmed | 4.09e-05 | 14 | 171 | 3 | 9373155 | ||
| Pubmed | 4.34e-05 | 257 | 171 | 8 | 16335952 | ||
| Pubmed | 6.24e-05 | 16 | 171 | 3 | 8875997 | ||
| Pubmed | 6.57e-05 | 44 | 171 | 4 | 19322198 | ||
| Pubmed | ABCA2 LARP1 CHSY1 ABCF2 EMC8 EDC4 AP3B1 CSGALNACT2 P3H1 MARCHF5 ENTPD1 ABCD3 NUP133 ETNK1 ATP11A NUP93 KLC1 | 6.89e-05 | 1168 | 171 | 17 | 19946888 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | AHCTF1 CHSY1 ABCF2 EMC8 EDC4 AP3B1 TUBB2A SLIT2 PTPRF CCNB2 P3H1 ABCD3 NUP133 NUP93 KLHDC4 | 6.99e-05 | 942 | 171 | 15 | 31073040 |
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 7.19e-05 | 3 | 171 | 2 | 16841095 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 7.19e-05 | 3 | 171 | 2 | 31985401 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 22003208 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 20139422 | ||
| Pubmed | Structure of Slitrk2-PTPδ complex reveals mechanisms for splicing-dependent trans-synaptic adhesion. | 7.19e-05 | 3 | 171 | 2 | 25989451 | |
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 7.19e-05 | 3 | 171 | 2 | 33656439 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 12594281 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 15880819 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 28924242 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 25568321 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 10930456 | ||
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 7.19e-05 | 3 | 171 | 2 | 22493081 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 24161960 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 30994973 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 6688039 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 19996274 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 7.19e-05 | 3 | 171 | 2 | 33032297 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 9763663 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 20639877 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 30297432 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 12875993 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 30279425 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 12427132 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 7.19e-05 | 3 | 171 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 7.19e-05 | 3 | 171 | 2 | 23898046 | |
| Pubmed | Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). | 7.19e-05 | 3 | 171 | 2 | 10602361 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 25703008 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 9784606 | ||
| Pubmed | Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer. | 7.19e-05 | 3 | 171 | 2 | 33455017 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 24190884 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 15883031 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 9892619 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 30636035 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 7.19e-05 | 3 | 171 | 2 | 30179254 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 8697799 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 23728777 | ||
| Interaction | GLMP interactions | 6.52e-06 | 84 | 168 | 7 | int:GLMP | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.03e-05 | 115 | 103 | 6 | 769 | |
| GeneFamily | Dyneins, axonemal | 1.15e-04 | 17 | 103 | 3 | 536 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.22e-04 | 21 | 103 | 3 | 813 | |
| GeneFamily | Tubulins | 4.24e-04 | 26 | 103 | 3 | 778 | |
| GeneFamily | Nucleoporins | 7.90e-04 | 32 | 103 | 3 | 1051 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.86e-03 | 394 | 103 | 8 | 471 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.41e-03 | 13 | 103 | 2 | 693 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.07e-03 | 51 | 103 | 3 | 870 | |
| GeneFamily | Beta 4-glycosyltransferases | 4.13e-03 | 17 | 103 | 2 | 425 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 5.71e-03 | 20 | 103 | 2 | 433 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN | POGLUT3 ABCA2 SIDT1 CHSY1 RNF157 DOCK5 PTPN4 GARIN3 PPP3CC ENTPD1 | 8.30e-07 | 200 | 171 | 10 | M9263 |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 6.75e-06 | 199 | 171 | 9 | M9178 | |
| Coexpression | WANG_RESPONSE_TO_ANDROGEN_UP | 3.66e-05 | 29 | 171 | 4 | M16075 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN | 4.77e-05 | 197 | 171 | 8 | M7345 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP | 5.31e-05 | 200 | 171 | 8 | M3707 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 5.31e-05 | 200 | 171 | 8 | M8559 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 5.31e-05 | 200 | 171 | 8 | M7322 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN | 5.31e-05 | 200 | 171 | 8 | M9272 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | VMP1 ANPEP NIBAN2 FGL2 DOCK5 NAMPT PTPRE FCGR1A CSTA LRP1 WDFY3 | 3.42e-10 | 199 | 171 | 11 | d0d286eafe935f9b3aaba5b783e8911251121b4a |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | VMP1 ANPEP FGL2 DOCK5 NAMPT CSF2RA PTPRE ENTPD1 LRP1 ATP11A WDFY3 | 3.61e-10 | 200 | 171 | 11 | 934c2efc780318c66d667ca75be0de350361d351 |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | DNAH3 ANPEP TTC16 CFAP210 DNAH1 CFAP54 SPATA17 ELAPOR1 PKP1 ELF5 | 5.29e-09 | 198 | 171 | 10 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ANPEP ABHD2 DOCK5 NAMPT CSF2RA PTPRE ENTPD1 LRP1 ATP11A WDFY3 | 5.29e-09 | 198 | 171 | 10 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | DNAH3 ANPEP TTC16 CFAP210 DNAH1 CFAP54 SPATA17 ELAPOR1 PKP1 ELF5 | 5.29e-09 | 198 | 171 | 10 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.54e-08 | 186 | 171 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 7.44e-08 | 197 | 171 | 9 | 5d826f4d7b7a46847c67e6bef38eb860bc808a6c | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 7.44e-08 | 197 | 171 | 9 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-08 | 197 | 171 | 9 | 383d598ce3f8f5fc98bef3300e4cf7b6992aec9c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.44e-08 | 197 | 171 | 9 | 3cc4e56a77f96a43f9b5a24cf1b9524c927ef795 | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.44e-08 | 197 | 171 | 9 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.77e-08 | 198 | 171 | 9 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.77e-08 | 198 | 171 | 9 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.77e-08 | 198 | 171 | 9 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.77e-08 | 198 | 171 | 9 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.77e-08 | 198 | 171 | 9 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.77e-08 | 198 | 171 | 9 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 7.77e-08 | 198 | 171 | 9 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 7.77e-08 | 198 | 171 | 9 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 8.11e-08 | 199 | 171 | 9 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 8.11e-08 | 199 | 171 | 9 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 8.11e-08 | 199 | 171 | 9 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.11e-08 | 199 | 171 | 9 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.11e-08 | 199 | 171 | 9 | 1761669ec514fdb4175042f11b9a31fa5687fc2b | |
| ToppCell | control-Classical_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.11e-08 | 199 | 171 | 9 | 171ccbd498774911143d55a27feeec745a0a7122 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-08 | 199 | 171 | 9 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 8.11e-08 | 199 | 171 | 9 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 8.46e-08 | 200 | 171 | 9 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.46e-08 | 200 | 171 | 9 | 8a480f487b52938d00b53bf4b18f067353d34419 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 8.46e-08 | 200 | 171 | 9 | f76d3647f8ab5f7be018b0697c911597198e03f5 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 8.46e-08 | 200 | 171 | 9 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 8.46e-08 | 200 | 171 | 9 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-07 | 180 | 171 | 8 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.16e-07 | 181 | 171 | 8 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-07 | 181 | 171 | 8 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-07 | 181 | 171 | 8 | 4a0f1b121570430afb100c589657d931184e124f | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-07 | 181 | 171 | 8 | 34b49092f71128898af3b311170c4ed8adfefcff | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 182 | 171 | 8 | 6685a0abd9c3a79d03b6a578e5d7fa86a9d74117 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 182 | 171 | 8 | f8eb35eb7f2b8ad47d527ae9ff8a9ddbcd2eedce | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.61e-07 | 183 | 171 | 8 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.09e-07 | 185 | 171 | 8 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.35e-07 | 186 | 171 | 8 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-07 | 188 | 171 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 7.45e-07 | 190 | 171 | 8 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.75e-07 | 191 | 171 | 8 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.06e-07 | 192 | 171 | 8 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.06e-07 | 192 | 171 | 8 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 8.38e-07 | 193 | 171 | 8 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-07 | 193 | 171 | 8 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.06e-07 | 195 | 171 | 8 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 9.06e-07 | 195 | 171 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-07 | 195 | 171 | 8 | b0dbaae86f5703ab62f925e0f36500274044884a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-07 | 195 | 171 | 8 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-07 | 195 | 171 | 8 | 403d874198a7bde626b0d0b4efad8dbb34060761 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD1c+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.06e-07 | 195 | 171 | 8 | cd4d61a463e0e87b711e08ceedee5bef5d735e64 | |
| ToppCell | Healthy-Classical_Monocyte|Healthy / disease group, cell group and cell class | 9.42e-07 | 196 | 171 | 8 | 27d24aa2fd4521cf7e410688ed3b11b2d9700dd2 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.42e-07 | 196 | 171 | 8 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.78e-07 | 197 | 171 | 8 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 9.78e-07 | 197 | 171 | 8 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.78e-07 | 197 | 171 | 8 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 9.78e-07 | 197 | 171 | 8 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.02e-06 | 198 | 171 | 8 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.02e-06 | 198 | 171 | 8 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD14_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.02e-06 | 198 | 171 | 8 | 128969698b2b0468cf5374f695e2d9fd02227d13 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.02e-06 | 198 | 171 | 8 | 5b31b6e008e05d6528656114fbe0ccae8ffe13b1 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.02e-06 | 198 | 171 | 8 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.02e-06 | 198 | 171 | 8 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-06 | 198 | 171 | 8 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-06 | 198 | 171 | 8 | a8338da2477ccf8e3d924de8dbe1056b98111532 | |
| ToppCell | Control-Myeloid-Classical_Monocyte|Control / Disease group, lineage and cell class | 1.02e-06 | 198 | 171 | 8 | 2b361d531c16e7a2d4cf676abb4421035d9bfe6e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-06 | 198 | 171 | 8 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | PBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-06 | 198 | 171 | 8 | 603846129560d5d6e6df27d6168f67f592e5e6e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-06 | 199 | 171 | 8 | cd93e8947bcf3c2d7e6d5bfd70300145fba15f74 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-06 | 199 | 171 | 8 | 27667838e065370d4536eaaf5b42ad322a714b96 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-06 | 199 | 171 | 8 | 0f3ce61bbae69f7e333ed8dacf7257645624e163 | |
| ToppCell | COVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class | 1.06e-06 | 199 | 171 | 8 | d0c230c3699955a80630b63ed18c770444c5dfe5 | |
| ToppCell | COVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class | 1.06e-06 | 199 | 171 | 8 | babbf3220cc811a1794032e06c6cec4dfc7bff2f | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 171 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-06 | 199 | 171 | 8 | 02256d86541be6851634283047fdc05fdf095114 | |
| ToppCell | IIF-Myeloid-CD14_Mono|IIF / Disease, Lineage and Cell Type | 1.06e-06 | 199 | 171 | 8 | accfb3d8ad3f03f9302f2056ca16c1be6231a351 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 171 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-06 | 199 | 171 | 8 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-06 | 199 | 171 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | IIF-Myeloid|IIF / Disease, Lineage and Cell Type | 1.06e-06 | 199 | 171 | 8 | e27b9dfd671c40c475b46dd0ff3195e1185efe77 | |
| ToppCell | Transverse-Monocyte|Transverse / Region, Cell class and subclass | 1.10e-06 | 200 | 171 | 8 | d70aeb57b98496474b97906505576640fdbdf34c | |
| ToppCell | mild-Classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-06 | 200 | 171 | 8 | 7beafb86fd77b022bd0549c8642a630937e364c3 | |
| ToppCell | Control-Control-Myeloid-CD14+_Monocyte|Control / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 97fb2599b353ef9899cd391122a189f1583fa4a6 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-CD14+_Monocyte|ICU-SEP / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 92c30e78c0e952bf4790f268d1a5facf3891682d | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-06 | 200 | 171 | 8 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 247040492b3c327f4144fc94cf210dc04eecc7b0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Transverse-(4)_Monocyte|Transverse / shred on region, Cell_type, and subtype | 1.10e-06 | 200 | 171 | 8 | 85714e8da539366b5bce071dfea8f8055de527bc | |
| ToppCell | Transverse-Monocyte-Monocyte|Transverse / Region, Cell class and subclass | 1.10e-06 | 200 | 171 | 8 | 96ecfab57e998134e164b4a62881ef6f2612bd8d | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-CD14+_Monocyte|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 172244415387e35747573c1b0a89b7e6fa7d1942 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | MS-IIF-Myeloid-CD14+_Monocyte|IIF / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 50d874971dabd3a3b26cc859d1977ffd01fad172 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.10e-06 | 200 | 171 | 8 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 1.10e-06 | 200 | 171 | 8 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid|COVID-19_Severe / Disease, condition lineage and cell class | 1.10e-06 | 200 | 171 | 8 | 1315bc0582b19c2fed91c740a1a7e9285c700df1 | |
| Disease | ptosis (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | Peeling skin syndrome, acral type | 3.15e-05 | 2 | 166 | 2 | C1853354 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 3.71e-05 | 12 | 166 | 3 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hydroquinone sulfate measurement | 9.40e-05 | 3 | 166 | 2 | EFO_0021157 | |
| Disease | urate measurement, bone density | ERBB4 AHCTF1 TENM2 GALNT18 DNAH1 DOCK5 FSIP2 SPATA17 PTPRD FCGR1BP DNAH8 FAM135A | 2.12e-04 | 619 | 166 | 12 | EFO_0003923, EFO_0004531 |
| Disease | peeling skin syndrome (is_implicated_in) | 4.65e-04 | 6 | 166 | 2 | DOID:0060283 (is_implicated_in) | |
| Disease | urate measurement | VMP1 USP34 DNAH3 ERBB4 ESRP1 DNAH1 SPATA17 PTPRF LRP1 STIP1 MINDY4 PAX7 HERC6 KLC1 | 5.63e-04 | 895 | 166 | 14 | EFO_0004531 |
| Disease | Liver carcinoma | 6.28e-04 | 507 | 166 | 10 | C2239176 | |
| Disease | response to angiotensin receptor blocker | 6.35e-04 | 30 | 166 | 3 | EFO_0010735 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 6.49e-04 | 7 | 166 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | blood viscosity | 7.00e-04 | 31 | 166 | 3 | EFO_0004301 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 8.61e-04 | 8 | 166 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | X-17676 measurement | 8.61e-04 | 8 | 166 | 2 | EFO_0800785 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 1.37e-03 | 10 | 166 | 2 | EFO_1000650, HP_0000131 | |
| Disease | transient cerebral ischemia (is_implicated_in) | 1.67e-03 | 11 | 166 | 2 | DOID:224 (is_implicated_in) | |
| Disease | microphthalmia (implicated_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 2.82e-03 | 50 | 166 | 3 | EFO_0008336, MONDO_0010679 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.99e-03 | 51 | 166 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | cancer biomarker measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0005127 | |
| Disease | 1,3,7-trimethylurate measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0021172 | |
| Disease | episodic memory | 3.16e-03 | 52 | 166 | 3 | EFO_0004333 | |
| Disease | pulmonary fibrosis (is_implicated_in) | 3.58e-03 | 16 | 166 | 2 | DOID:3770 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.93e-03 | 447 | 166 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 4.05e-03 | 17 | 166 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | ischemia (implicated_via_orthology) | 4.05e-03 | 17 | 166 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 4.10e-03 | 57 | 166 | 3 | EFO_0000768 | |
| Disease | neuroblastoma | 4.24e-03 | 116 | 166 | 4 | EFO_0000621 | |
| Disease | insulin resistance | 4.51e-03 | 59 | 166 | 3 | EFO_0002614 | |
| Disease | amino acid measurement | 5.20e-03 | 678 | 166 | 10 | EFO_0005134 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 5.42e-03 | 63 | 166 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 5.42e-03 | 63 | 166 | 3 | EFO_0022239 | |
| Disease | acne | 5.52e-03 | 125 | 166 | 4 | EFO_0003894 | |
| Disease | brain age measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0010602 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVLDKRYNVYGYTGQ | 681 | Q13523 | |
| EYSTKYFYKQNGRIR | 1261 | Q15303 | |
| SNVNYYNRLYKGEFK | 81 | Q52LR7 | |
| YTGNYDQYVKTRLEL | 306 | Q9UG63 | |
| RIEAEQNALYSYQKY | 881 | Q96N23 | |
| HYKLYQYVLGQDQQV | 121 | Q6P047 | |
| YGYLKDYAVQQYVRD | 376 | Q9UKU7 | |
| NTARYYAKIYAAEAQ | 1986 | Q86TB3 | |
| QYIRTFVDYAQKNGY | 141 | P08910 | |
| QIVYKDGLLYVYASN | 81 | P51813 | |
| YYNVDVLKYQVSSNG | 651 | Q0JRZ9 | |
| PENIQFDVYYKLYQQ | 36 | Q92624 | |
| FDVYYKLYQQGRLCQ | 41 | Q92624 | |
| DYRGLIKLYNSIGNY | 516 | Q92624 | |
| LLNLNVTGYYRVNYD | 621 | P15144 | |
| QFNINVPASVYAKYY | 281 | Q8N7R7 | |
| EYLYFILQNIRTQGY | 116 | Q9UKW6 | |
| IQKVFYQGRYYDSLA | 261 | Q16853 | |
| QYILNLGKYDQNYDI | 556 | O00203 | |
| QYVLSLAKYDQNYDI | 561 | Q13367 | |
| VKEILNFFQGYQYAT | 646 | Q6NXG1 | |
| RQALAYLEQSYKNYT | 256 | Q8N1F7 | |
| VGYLITGYQRQLNYK | 1011 | P20742 | |
| VQYFNVASAIYAKYK | 291 | Q8IUH3 | |
| YLSFYVYDKNVLQRD | 101 | Q15283 | |
| KYYYGNLIAVSNSFL | 131 | Q6P2E9 | |
| LLQIDYYNLTKFYGT | 536 | P25092 | |
| YNYLQVAYFKINKLE | 146 | Q32P28 | |
| KLQEEYTRYQYFLQI | 116 | P29074 | |
| YTRYQYFLQIKQDIL | 121 | P29074 | |
| YGLVLYENKAAYERQ | 96 | Q96TA1 | |
| QYGQYGQTAVDYLAK | 461 | P23759 | |
| YFELETFYQQLYKTQ | 441 | Q7Z5J8 | |
| LCQNQGKYEAVERYY | 346 | Q9NSK0 | |
| LVYNVLYYRNGKAFK | 131 | Q92637 | |
| LQFLQQYYLIYDSGD | 346 | Q9H4D5 | |
| LGAVLQNQYGYEVYK | 336 | Q5T3U5 | |
| QNQYGYEVYKVTLQA | 341 | Q5T3U5 | |
| EFVLKANYEYYVQGQ | 1141 | Q8WUM0 | |
| VYEGKLADQYYQRTL | 266 | Q8NA72 | |
| AQYYKVLVDNGYENI | 556 | Q8WXD9 | |
| YIKRQIEYYFSVDNL | 406 | Q6PKG0 | |
| YINASFIDGYRQKDY | 481 | P23469 | |
| YEPLTQLKNVRANYY | 201 | Q9UJA3 | |
| RGRYQFNYYEAKQAC | 156 | Q9GZV7 | |
| NYYRIQLKPEQFSSY | 636 | Q7L2J0 | |
| SAIYSQLGNAYFYLK | 66 | Q86YR5 | |
| IYFQFQNLRQLGSKY | 76 | P04035 | |
| YIYGVTYINNRVFKI | 4101 | Q07954 | |
| LKTYGFYNNSIIIYS | 311 | Q5FYB0 | |
| VNLKQSGTVNFEYYY | 181 | Q6UXG2 | |
| GNYAYCQVVRELVKY | 221 | Q8IYD8 | |
| SYKNQSYEVRLVLYG | 946 | Q5H9U9 | |
| FTIYDNQYLYTGKNL | 4196 | Q5CZC0 | |
| TQPKYQYVLNEFYRI | 96 | A6PVY3 | |
| KFYNVDLFQRGFYQI | 16 | Q9P2D6 | |
| ALNELYFYVTKYRQE | 1826 | P51805 | |
| RNQGYYYSDKIQIFN | 896 | Q7Z5P9 | |
| NIGFAKQYYNLHYRA | 16 | P16499 | |
| SYLSFINGYKNIYAE | 3041 | Q96JB1 | |
| NKRDYVSKYIDYIFN | 851 | Q8IVU3 | |
| EYFNGVKYNTTRNAY | 66 | Q13324 | |
| QKLREEGYLAYYLQG | 111 | Q99956 | |
| LNVYYNYSGQVKCLN | 331 | P42785 | |
| AFKVYFKQQQYLRQA | 251 | Q9NX47 | |
| ALQFRLYGKDYNVYT | 236 | P49961 | |
| SRRQYQEKYKQVEQY | 356 | Q9P1Z3 | |
| YAVKSLSNENYGVYN | 596 | Q7Z553 | |
| KRDYVSKYINYIFND | 861 | Q9UII4 | |
| AYAKEYRKYLELNNN | 746 | Q9P2D7 | |
| YYLNRTANEKVLTAY | 381 | P0DPD8 | |
| NYGKEYYQALLQEQE | 51 | Q8N6G5 | |
| YKGQNTYEEAAVYIQ | 291 | P19086 | |
| KYGVAIYNYNASQDV | 11 | Q9H7D0 | |
| NLKQQYYTGYTENEV | 326 | O95067 | |
| KLIGISQRDYTQYYD | 186 | O75794 | |
| NAYELYQIEITKNYA | 2451 | Q8TD57 | |
| NLKFVLQVYRDYYLT | 621 | Q9HCG7 | |
| KRRALGNNFYEYYVD | 36 | P30047 | |
| VYKVRNKLDGQYYAI | 181 | Q9BQI3 | |
| ESYYQRYLNGVVKNG | 66 | Q9Y2V0 | |
| QDLFRKFGYNAYLSN | 141 | Q9NY28 | |
| YVQQSEFYLEPNIKY | 276 | Q5VWK5 | |
| RVALKQFQYYGYNAY | 111 | Q6P9A2 | |
| YRKFQYLLNPRQVYS | 456 | Q9Y6T7 | |
| AYNEYINEYYAKIGQ | 1961 | Q9BZC7 | |
| VQYKTQVVAGTNYYI | 41 | P01040 | |
| LVYNVLYYRNGKAFK | 131 | P12314 | |
| YDQFYVANEFLKYRL | 316 | Q14314 | |
| YGVVKLAYNENDNTY | 176 | Q96RR4 | |
| FNGQKTFLYNELYVY | 86 | Q8TBB5 | |
| FNYYENVLEKNSKRY | 41 | A6NC97 | |
| QRLLQYLYKQIYQTY | 261 | P48723 | |
| YPVIQNYYTSRRQKF | 696 | Q8WYP5 | |
| NNLYYTAGKEVVYFV | 26 | Q6ZMW3 | |
| SYVIAGYYQANERVK | 86 | O43402 | |
| DFLGYAIVRFNQYFK | 426 | Q9HBU6 | |
| KFYNVDLFQRGYYQI | 16 | Q49AJ0 | |
| GSQYLRTKYNLYLNY | 261 | Q9NQZ2 | |
| GIVKLNIYFQEFNYR | 491 | P51168 | |
| AEKQAVYQQVYRPVY | 376 | O94829 | |
| YLYKRESGQQYFSII | 121 | Q9BV19 | |
| RTYQKLSYLDFQYQL | 241 | P15509 | |
| KLGEYYLQNAFLVAY | 421 | P02771 | |
| NQGKYEEVEYYYQRA | 351 | Q07866 | |
| NYYEVGSNRGAYVKL | 511 | O14830 | |
| FYYNRAFTKNIIKYD | 476 | Q68BL7 | |
| INANYIDGYRKQNAY | 1406 | P10586 | |
| VNANYIDGYRKQNAY | 1411 | P23468 | |
| NNYRLAQAYLDKYYT | 36 | O60882 | |
| LGGTYVQRENLYKYF | 261 | Q96CW9 | |
| VQRENLYKYFYAISN | 266 | Q96CW9 | |
| SFLEYYRKQYNQEIT | 341 | Q96J94 | |
| SQDEKYQAIGAYYIQ | 256 | Q13835 | |
| QLYNRGEYNIFKYAP | 31 | Q8TC56 | |
| LYIDAGNNVVYKQYE | 431 | Q6KF10 | |
| VKKLQRRDNTFYYYN | 56 | Q5JSS6 | |
| NKYVVRLQEDSYNYL | 161 | O75529 | |
| KYRKNIGEIRQYYQE | 1561 | Q5TCS8 | |
| GRKQYQLTVQVAYYT | 71 | Q96L03 | |
| YLLQEIYGIENKYNT | 246 | Q96PX1 | |
| QINYGKNTIAYDRYI | 141 | Q14493 | |
| YRQIAKAYARIGNSY | 296 | P31948 | |
| QYLFIKLYEAGLAYQ | 186 | Q15031 | |
| INGYKINVYFLDYGN | 556 | B5MCY1 | |
| DLGQLEYKFQYAYFR | 226 | Q7Z6M4 | |
| SQYGLKIYAQVYDSL | 641 | Q9NTG1 | |
| AYAINVSQKRKYRQY | 126 | Q8WVK2 | |
| YLTGNYLQTVYKNDL | 381 | Q9H156 | |
| KNTARQYAYFYKVIQ | 211 | Q86TU7 | |
| TSVYQYLGFQVQKIY | 11 | P0DKX4 | |
| QKEFNSLYFYQRAGK | 1376 | Q5VXU9 | |
| VGIFDIKYRGQYQKY | 471 | Q8WXD0 | |
| RINVYYNEAAGNKYV | 46 | Q13885 | |
| IKQLQYTAYGEIYYD | 2386 | Q9NT68 | |
| ETVFYGLQYILNKYL | 56 | P43490 | |
| YQGEEQAVQLYYKVF | 4521 | Q9P2P6 | |
| NYQDVETLYNFLIKY | 821 | Q5T5J6 | |
| INYNPFDQKLYVYND | 481 | Q6UX06 | |
| FDQKLYVYNDGYLLN | 486 | Q6UX06 | |
| KYTIIKFFQNQRYYL | 686 | Q01826 | |
| YLQAFTYYKMGNLDN | 166 | P28288 | |
| DLYLVLDNAFYKNYN | 221 | O15204 | |
| LNQKYFVGQEALYKY | 51 | Q8TDG2 | |
| AKQYQFYQTERVKNF | 141 | Q0VFZ6 | |
| LFYENYEQNKKGYIR | 276 | Q86X52 | |
| YIRISELVQYFFYKN | 876 | P98196 | |
| YYQVLQKYAERQSSK | 461 | Q7Z4H8 | |
| NYLDVYNNKAAVLKY | 306 | P48454 | |
| YESYTGQNVKLRYFL | 116 | Q4G0F5 | |
| ENIFEIYLSYNKYLQ | 456 | O15455 | |
| YKEYQERQQNALKYV | 2326 | Q8IZQ1 | |
| RLFDLYYYDGLANQQ | 696 | Q4G0A6 | |
| YYYDGLANQQEQIRL | 701 | Q4G0A6 | |
| YLVVLYYNANRAFQK | 86 | Q9Y3B4 | |
| LFQGLYQRSYNYQEV | 111 | Q9NXL6 | |
| RINVYYNEATGNKYV | 46 | Q9BVA1 | |
| RINVYYNEATGGKYV | 46 | P68371 | |
| ERIRDYYQKQQGYAA | 1456 | O94813 | |
| YQRYKAGVDDFIQNY | 166 | A8MWL6 | |
| HYYSYIIQRNGKDDQ | 1881 | O00507 | |
| YQYAELGKLYSVVSQ | 2221 | O00507 | |
| YNLKNSSRIYYENIL | 111 | Q9NZM6 | |
| QRQEYVMNDYGFIYQ | 156 | O43548 | |
| GYITRYFYNNQTKQC | 136 | P10646 | |
| YNNRGQIKYFRVDFY | 61 | Q5I0X7 | |
| LIVNQDGFYYLYANI | 206 | O14788 | |
| AFLREYLYVYKNVSQ | 641 | Q9Y2L5 | |
| QYYLYRAKSRQLLQN | 441 | Q8NEE8 | |
| EQYKINIYYQGLDTI | 961 | Q5SVZ6 | |
| AAIQYINSYYINGKT | 1116 | Q70CQ2 | |
| EGATYQKYRLNFYIQ | 261 | Q8WY21 | |
| GFSLVNQIYYYHNVK | 671 | Q8IWV8 | |
| ANGLNQLYFYYEETK | 531 | Q9UBN4 | |
| KRFYLEYYNNNRTTP | 201 | Q9P2T0 | |
| EVNKYQYLLTGRVYD | 96 | P35625 | |
| NRQFHYGVFYAYVKL | 306 | Q8N8Y2 | |
| QYVQRIEKQFLLYAY | 101 | Q96GC9 | |
| GFFQYYRERCHQKVY | 441 | A6NN73 | |
| KIYAQIFREYLTYLN | 241 | P23276 | |
| AEGSLYQQRFKYVFY | 201 | Q86W24 | |
| YQQRFKYVFYLNGRE | 206 | Q86W24 | |
| AASNYYKGENFRRQY | 401 | Q8IZF0 | |
| FSKNYQDYEYLINVI | 51 | P60201 |